Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Tun GSZ, Robinson K, Marshall L, Wright A, et al. The effect of infliximab dose escalation in inflammatory bowel disease patients with antibodies to infliximab. Eur J Gastroenterol Hepatol 2022;34:295-301.
PMID: 35100176


Privacy Policy